Isoptin Sr (Verapamil Hydrochloride)

• Verapamil is used to treat cardiovascular conditions that involve elevated vascular tone or abnormal cardiac conduction.
• Hypertension: lowers systemic blood pressure by causing vasodilation of peripheral arteries, reducing cardiac afterload.
• Angina pectoris: eases chest discomfort by decreasing myocardial contractility and oxygen consumption, improving coronary blood flow.
• Cardiac arrhythmias: controls irregular heartbeats such as atrial fibrillation or supraventricular tachycardia by slowing atrioventricular nodal conduction.
• Post‑operative atrial fibrillation: helps prevent new‑onset arrhythmia after cardiac surgery by maintaining a stable heart rate.

• Verapamil blocks L‑type calcium channels in cardiac myocytes and vascular smooth muscle. By inhibiting calcium influx, it reduces myocardial contractility, slows sinoatrial and atrioventricular nodal conduction, and promotes vasodilation of arterial vessels, leading to decreased heart rate, lowered cardiac output, and reduced peripheral resistance. The net effect is a reduction in myocardial oxygen demand and stabilization of abnormal electrical activity.

Verapamil may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Constipation: reduced gastrointestinal motility leading to hard stools.
• Dizziness or light‑headedness: transient drop in blood pressure.
• Headache: mild to moderate intensity, often related to vasodilation.
• Peripheral edema: swelling of ankles due to fluid accumulation.

Serious or Rare Side Effects

• Severe bradycardia: markedly slowed heart rate that may require medical attention.
• Heart block: impairment of electrical conduction between atria and ventricles.
• Hypotension: abrupt and significant drop in blood pressure causing fainting.

When prescribing Verapamil, clinicians should consider several precautionary measures to ensure safe use.

• Cardiac function assessment: evaluate baseline heart rate and conduction abnormalities before initiation.
• Concomitant beta‑blocker use: avoid combining with other negative chronotropes without monitoring.
• Liver impairment: adjust therapy in patients with moderate to severe hepatic dysfunction.
• Drug‑induced gingival overgrowth: monitor oral health during long‑term therapy.
• Pregnancy and lactation: use only if potential benefit justifies risk; discuss with obstetrician.
• Store at ambient temperature: keep below 25 °C in original container, protect from moisture and light.

Verapamil interacts with several medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may cause toxic Verapamil levels.
• Digoxin: increased risk of digoxin toxicity due to altered clearance.
• Beta‑blockers (e.g., propranolol): excessive bradycardia or AV block.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce Verapamil effectiveness.
• Antacids containing aluminum or magnesium: decrease absorption if taken simultaneously.
• Statins metabolized by CYP3A4 (e.g., simvastatin): may increase statin concentrations, monitor for myopathy.